Lorena García-Hevia

15PUBLICATIONS
30CO-AUTHORS
Molecular targetsMedical bacteriologyMedical biotechnology diagnostics (incl. biosensors)NanomaterialsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Apr 22, 2025
Targeted Tumor Microenvironment Delivery of Floxuridine Prodrug via Soluble Silica Nanoparticles in Malignant Melanoma as a Model for Aggressive Cancer Treatment.

Andrés Ramos-Valle, Arnau Domínguez, Natalia Navarro

|Jun 28, 2023
Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT).

Alexis Dorta-Gorrín, Jesús Navas-Méndez, Mónica Gozalo-Margüello

|Dec 05, 2022
Shiga Toxin-B Targeted Gold Nanorods for Local Photothermal Treatment in Oral Cancer Clinical Samples.

Elena Navarro-Palomares, Lorena García-Hevia, Jesús Galán-Vidal

|Apr 23, 2022
Gb3/cd77 Is a Predictive Marker and Promising Therapeutic Target for Head and Neck Cancer.

Lorena García-Hevia, Débora Muñoz-Guerra, Íñigo Casafont

|Oct 13, 2021
Targeting Nanomaterials to Head and Neck Cancer Cells Using a Fragment of the Shiga Toxin as a Potent Natural Ligand.

Elena Navarro-Palomares, Lorena García-Hevia, Esperanza Padín-González

Pageof 3